Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs-Reference-Cited by-同舟云学术

Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs

Published:2022-12-21 Issue:6 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Landaverde Lena¹²³,Turcinovic Jacquelyn⁴⁵⁶,Doucette-Stamm Lynn²,Gonzales Kevin⁷⁸,Platt Judy⁷,Connor John H.⁴⁵⁶⁹^ORCID,Klapperich Catherine¹²³^ORCID

Affiliation:

1. Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA

2. Clinical Testing Laboratory, Boston University, Boston, Massachusetts, USA

3. Precision Diagnostics Center, Boston University, Boston, Massachusetts, USA

4. Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA

5. National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA

6. Program in Bioinformatics, Boston University, Boston, Massachusetts, USA

7. Student Health Services, Healthway, Boston University, Boston, Massachusetts, USA

8. Office of Research, Boston University, Boston, Massachusetts, USA

9. Center for Emerging Infectious Disease Research and Policy, Boston University, Boston, Massachusetts, USA

Abstract

Our results suggest BinaxNOW can rule in SARS-CoV-2 infection but would miss infections if RDTs were exclusively used.

Funder

Boston University

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01307-22

Reference28 articles.

1. Holiday gatherings, mobility and SARS-CoV-2 transmission: results from 10 US states following Thanksgiving

2. Centers for Disease Control and Prevention. 2021. First confirmed case of Omicron variant detected in the United States. https://www.cdc.gov/media/releases/2021/s1201-omicron-variant.html. Accessed 30 January 2022.

3. Pulliam JRC van Schalkwyk C Govender N von Gottberg A Cohen C Groome MJ Dushoff J Mlisana K Moultrie H. 2021. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. medRxiv. https://www.medrxiv.org/content/10.1101/2021.11.11.21266068v2.

4. Venkatakrishnan AJ Anand P Lenehan PJ Suratekar R Raghunathan B Niesen MJM Soundararajan V. 2021. Omicron variant of SARS-CoV-2 harbors a unique insertion mutation of putative viral or human genomic origin. OSF Preprints. https://osf.io/f7txy/. Accessed 30 January 2022.

5. Pilarowski G Lebel P Sunshine S Liu J Crawford E Marquez C Rubio L Chamie G Martinez J Peng J Black D Wu W Pak J Laurie MT Jones D Miller S Jacobo J Rojas S Rojas S Nakamura R Tulier-Laiwa V Peterson M Havlir DV CLIAHUB Consortium DeRisi J. 2020. Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco. medRxiv. http://medrxiv.org/lookup/doi/10.1101/2020.11.02.20223891. Accessed 30 January 2022.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing SARS-CoV-2 omicron variant detection: Towards faster and more reliable methods;Talanta;2024-01

2. COVID‐19 rapid antigen tests approved for self‐testing in Australia: published diagnostic test accuracy studies and manufacturer‐supplied information. A systematic review;Medical Journal of Australia;2023-10-30

3. Sensitivity of rapid antigen tests against SARS-CoV-2 Omicron and Delta variants;Journal of Clinical Microbiology;2023-10-24